Shubham Pant, MD, MBBS, discussed the use of zanidatamab and the HERIZON-BTC-01 trial in HER2-positive biliary tract cancer ...

The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand name Ziihera, it is a first-of-a-kind treatment for patients with ...

Sarrah Strimel Bentley is an optimist – even when it comes to her journey with early breast cancer. The new mother and philanthropist discusses why she’s empowered to live a happy and healthy life.

The percentage of long-term care residents receiving an antibiotic decreased from 51% to 44% from 2013 to 2021.

Currently, chemotherapy remains a common treatment for biliary tract cancers, which have a limited survival rate.

The agency has approved Ziihera for adults with previously treated, unresectable or metastatic HER2-positive biliary tract ...

When Ed O. went to the ER for shortness of breath and trembling, he never imagined he’d receive a diagnosis of unresectable ...

What the symptoms are: Lethargy, nausea, vomiting, loss of appetite, joint pain and dark-colored urine are all common ...

The U.S. Supreme Court turned away on Monday a bid by Alvogen's subsidiary Norwich Pharmaceuticals to sell a generic version ...

Women may struggle to get diagnoses for health problems, including sleep apnea and heart conditions, early enough if their ...

Amid the ongoing McDonald's E. coli investigation, Fox News Digital spoke with several food safety experts about the most prevalent foodborne illnesses and how to prevent them.

Almost half of adults and children with neurofibromatosis type 1 (NF1) responded to the investigational MEK inhibitor ...